Erratum: Antimetastatic activity of MONCPT in preclinical melanoma mice model (Investigational New Drugs DOI: 10.1007/s10637-009-9323-8);Antimetastatic activity of MONCPT in preclinical melanoma mice model

Investigational New Drugs

Volumn 28, Issue 6, 2010, Pages 800-811

  Yang, Xiao Chun ^a   Tu, Chong Xing ^a   Luo, Pei Hua ^a   Zhu, Hong ^a   Zhu, Di Feng ^a   Wu, Hong Hai ^a   Zhou, Xing Lu ^a   Lu, Wei ^b   He, Qiao Jun ^a   Yang, Bo ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antitumor; Melanoma; Metastasis; MONCPT

Indexed keywords

10 METHOXY 9 NITROCAMPTOTHECIN; ANTINEOPLASTIC AGENT; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CANCER INHIBITION; CANCER INVASION; CARCINOMA; CARCINOMA CELL; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; LUNG METASTASIS; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; TUMOR XENOGRAFT;

EID: 78549239249     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-010-9469-4     Document Type: Erratum

References (50)

1. AF Chambers AC Groom IC MacDonald 2002 Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 8 563 572 1:CAS:528: DC%2BD38XlslGqsLw%3D 10.1038/nrc865 12154349 (Pubitemid 37328923)
2. CE Brinckerhoff LM Matrisian 2002 Matrix metalloproteinases: a tail of a frog that became a prince Nat Rev Mol Cell Biol 3 3 207 214 1:CAS:528: DC%2BD38XitFShsLs%3D 10.1038/nrm763 11994741
3. S Zucker J Vacirca 2004 Role of matrix metalloproteinases (MMPs) in colorectal cancer Cancer Metastasis Rev 23 101 117 1:CAS:528: DC%2BD3sXnsFansrY%3D 10.1023/A:1025867130437 15000152 (Pubitemid 38221598)
4. UB Hofmann R Houben EB Brocker JC Becker 2000 Matrix metalloproteinases in human melanoma J Invest Dermatol 115 3 337 344 1:CAS:528:DC%2BD3cXmsFWhtr0%3D 10.1046/j.1523-1747.2000.00068.x 10951266
5. JS Rao 2003 Molecular mechanisms of glioma invasiveness: the role of proteases Nat Rev Cancer 3 7 489 501 1:CAS:528:DC%2BD3sXltVSqtr8%3D 10.1038/nrc1121 12835669
6. EI Deryugina JP Quigley 2006 Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 25 1 9 34 1:CAS:528:DC%2BD28Xktlaksr4%3D 10.1007/s10555-006-7886-9 16680569 (Pubitemid 43723979)
7. C Cuvier A Jang RP Hill 1997 Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L 1 B)secretion Clin Exp Metastasis 15 19 25 1:CAS:528: DyaK2sXhs1Oktr4%3D 10.1023/A:1018428105463 9009102 (Pubitemid 27095148)
8. SD Young RS Marshall RP Hill 1988 Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells Proc Natl Acad Sci 85 9533 9537 1:CAS:528:DyaL1MXntlWrsQ%3D%3D 10.1073/pnas.85.24.9533 3200838 (Pubitemid 19027161)
9. EK Rofstad T Danielsen 1999 Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis Br J Cancer 80 11 1697 1707 1:CAS:528:DyaK1MXlvFGnsbc%3D 10.1038/sj.bjc.6690586 10468285 (Pubitemid 29389621)
10. GL Semenza 2001 Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology Trends Mol Med 7 345 350 1:CAS:528:DC%2BD3MXmtFaks7s%3D 10.1016/S1471-4914(01)02090-1 11516994 (Pubitemid 32735019)
11. A Weidemann RS Johnson 2008 Biology of HIF-1alpha Cell Death Differ 15 621 627 1:CAS:528:DC%2BD1cXjtl2jurc%3D 10.1038/cdd.2008.12 18259201 (Pubitemid 351405064)
12. G Semenza 2002 Singal transduction to hypoxia-inducible factor 1 Biochem Pharmacol 64 993 998 1:CAS:528:DC%2BD38Xms1ymsLg%3D 10.1016/S0006-2952(02)01168- 1 12213597 (Pubitemid 35232274)
13. Y Dor R Porat E Keshet 2001 Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis Am J Physiol Cell Physiol 280 C1367 C1374 1:CAS:528:DC%2BD3MXksFKntbY%3D 11350731
14. W Risau 1997 Mechanisms of angiogenesis Nature (Lond) 386 671 674 1:STN:280:DyaK2s3mtlGksg%3D%3D 10.1038/386671a0
15. P Carmeliet Y Dor, et al. 1998 Role of HIF-1 in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis Nature 394 485 490 1:CAS:528:DyaK1cXltVGqsbg%3D 10.1038/28867 9697772 (Pubitemid 28373960)
16. MT Canning LM Postovit SH Clarke, et al. 2001 Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells Exp Cell Res 267 88 94 1:CAS:528:DC%2BD3MXksVWqtL4%3D 10.1006/excr.2001.5243 11412041 (Pubitemid 32579144)
17. B Sun D Zhang S Zhang W Zhang H Guo X Zhao 2007 Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma Cancer Lett 249 2 188 197 1:CAS:528:DC%2BD2sXjsVektbw%3D 10.1016/j.canlet.2006.08.016 16997457 (Pubitemid 46452927)
18. P Luo Q He X He Y Hu W Lu Y Cheng B Yang 2006 Potent antitumor activity of 10-methoxy-9-nitrocamptothecin Mol Cancer Ther 5 962 968 1:CAS:528: DC%2BD28XjvFCkt78%3D 10.1158/1535-7163.MCT-05-0385 16648567 (Pubitemid 43724596)
19. X Yang P Luo B Yang Q He 2006 Antiangiogenesis response of endothelial cells to the antitumour drug 10-methoxy-9-nitrocamptothecin Pharmacol Res 54 5 334 340 1:CAS:528:DC%2BD28XhtVyksLnF 10.1016/j.phrs.2006.06.001 16931034 (Pubitemid 44528998)
20. ET Wong A Berkenblit 2004 The role of topotecan in the treatment of brain metastases Oncologist. 9 1 68 79 1:CAS:528:DC%2BD2cXhs1Smt7c%3D 10.1634/theoncologist.9-1-68 14755016 (Pubitemid 38134015)
21. S Shimada N Hayashi, et al. 2002 Irinotecan plus low-dose cisplatin for α-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases Surg Today 32 1075 1080 10.1007/s005950200217 12541026 (Pubitemid 36221345)
22. JY Douillard D Cunningham, et al. 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 9209 1041 1047 1:CAS:528:DC%2BD3cXisFOnsb4%3D 10.1016/S0140-6736(00)02034-1 10744089
23. MC Wani AW Nicholas ME Wall 1986 Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues J Med Chem 29 2858 2863 10.1021/jm00161a035 (Pubitemid 17182317)
24. B Yang CP Reynolds 2005 Tirapazamine cytotoxicity for neuroblastoma is p53 dependent Clin Cancer Res 11 2774 2780 1:CAS:528:DC%2BD2MXivFKisb8%3D 10.1158/1078-0432.CCR-04-2382 15814660 (Pubitemid 40569480)
25. P Skehan R Storeng D Scudiero, et al. 1990 New colorimetric cytotoxicity assay for anticancer-drug screening J Natl Cancer Inst 82 1107 1112 1:CAS:528:DyaK3cXltVylsL8%3D 10.1093/jnci/82.13.1107 2359136
26. H Zhu M Huang, et al. 2007 R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II Mol Cancer Ther 6 2 484 495 1:CAS:528:DC%2BD2sXhvVWku7k%3D 10.1158/1535-7163.MCT-06-0584 17308047 (Pubitemid 46332450)
27. J Zhang Y Shen J Liu D Wei 2005 Antimetastatic effect of prodigiosin through inhibition of tumor invasion Biochem Pharmacol 69 3 407 414 1:CAS:528:DC%2BD2MXivVSgtg%3D%3D 10.1016/j.bcp.2004.08.037 15652232 (Pubitemid 40094501)
28. K Nakagawa Y Sasaki S Kato N Kubodera T Okano 2005 22-Oxa-1alpha, 25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer Carcinogenesis 26 6 1044 1054 1:CAS:528:DC%2BD2MXkvVShtLw%3D 10.1093/carcin/bgi049 15718253 (Pubitemid 41214297)
29. Q Huang HM Shen CN Ong 2004 Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB Biochem Pharmacol 68 2 361 371 1:CAS:528:DC%2BD2cXkvV2hsLw%3D 10.1016/j.bcp.2004.03.032 15194008 (Pubitemid 38757705)
30. M Ying C Tu H Ying Y Hu Q He B Yang 2008 MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway J Pharmacol Exp Ther 325 3 758 765 1:CAS:528:DC%2BD1cXmsVOrsbY%3D 10.1124/jpet.107.135657 18323457 (Pubitemid 351724320)
31. M Yang P Jiang, et al. 1999 Genetically fluorescent melanoma bone and organ metastasis models Clin Cancer Res 5 11 3549 3559 1:STN:280: DC%2BD3c%2FlsFKrug%3D%3D 10589771
32. P Vihinen VM Kahari 2002 Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int J Cancer 99 2 157 166 1:CAS:528: DC%2BD38XivFyrsr4%3D 10.1002/ijc.10329 11979428 (Pubitemid 34309470)
33. LL Ho WJ Chen SY Lin-Shiau JK Lin 2002 Penta-O-galloyl-beta-Dglucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1 Eur J Pharmacol 453 2-3 149 158 1:CAS:528:DC%2BD38XotVChu7o%3D 10.1016/S0014-2999(02)02340-3 12398898 (Pubitemid 35223504)
34. SM Ellerbroek JM Halbleib M Benavidez JK Warmka EV Wattenberg MS Stack, et al. 2001 Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association Cancer Res 61 5 1855 1861 1:CAS:528:DC%2BD3MXit1Ohu70%3D 11280738
35. J Westermarck VM Kahari 1999 Regulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 8 781 792 1:CAS:528:DyaK1MXjtFGksrs%3D 10224222
36. P Bischof A Meisser A Campana 2002 Control of MMP-9 expression at the maternal-fetal interface J Reprod Immunol 55 1-2 3 10 1:CAS:528: DC%2BD38XksVSgs7Y%3D 10.1016/S0165-0378(01)00142-5 12062817 (Pubitemid 34626147)
37. BH Jiang G Jiang JZ Zheng Z Lu T Hunter PK Vogt 2001 Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor1 Cell Growth Differ 12 363 369 1:CAS:528:DC%2BD3MXlsVCgur8%3D 11457733
38. E Hur KY Chang E Lee SK Lee H Park 2001 Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha Mol Pharmacol 59 1216 1224 1:CAS:528:DC%2BD3MXjt1aqtL4%3D 11306706
39. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10.1016/S0092-8674(00)81683-9 10647931
40. A Tiwari N Kumar R Bajpai P Lal 2007 Bone metastasis from ovarian cancer J Cancer Res Ther 3 1 34 36 10.4103/0973-1482.31969 17998717
41. CA Papadimitriou G Fountzilas, et al. 2008 Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study Gynecol Oncol 111 1 27 34 1:CAS:528: DC%2BD1cXhtFOgsr%2FO 10.1016/j.ygyno.2008.06.001 18644619 Epub 2008 Jul 21
42. M Yang, et al. 2000 Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases Proc Natl Acad Sci 97 3 1206 1211 1:CAS:528:DC%2BD3cXpvFelsg%3D%3D 10.1073/pnas.97.3.1206 10655509 (Pubitemid 30080837)
43. R Hoffman, et al. 2002 Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mice models Lancet Oncol 3 9 546 556 1:CAS:528:DC%2BD38Xms1Grsb8%3D 10.1016/S1470-2045(02)00848-3 12217792 (Pubitemid 34993642)
44. S Paris R Sesboüé 2004 Metastasis models: the green fluorescent revolution? Carcinogenesis 25 12 2285 2292 1:CAS:528: DC%2BD2cXhtVCrsrzF 10.1093/carcin/bgh219 15217904 (Pubitemid 39625167)
45. T Bogenrieder M Herlyn 2003 Axis of evil: molecular mechanisms of cancer metastasis Oncogene 22 6524 6536 1:CAS:528:DC%2BD3sXnsl2rsr0%3D 10.1038/sj.onc.1206757 14528277
46. K Nabeshima T Inoue Y Shimao T Sameshima 2002 Matrix metalloproteinases in tumor invasion: role for cell migration Pathol Int 52 255 264 1:CAS:528:DC%2BD38XmtFWlsrY%3D 10.1046/j.1440-1827.2002.01343.x 12031080 (Pubitemid 34587810)
47. S Abiru K Nakao T Ichikawa K Migita M Shigeno M Sakamoto, et al. 2002 Aspirin and NS-398 inhibit hepatocyte growth factorinduced invasiveness of human hepatoma cells Hepatology 35 1117 1124 1:CAS:528:DC%2BD38XktF2hurY%3D 10.1053/jhep.2002.32676 11981761 (Pubitemid 34454008)
48. ZM Shao J Wu ZZ Shen SH Barsky 1998 Genistein exerts multiple suppressive effects on human breast carcinoma cells Cancer Res 58 4851 4857 1:CAS:528:DyaK1cXnt1yis7w%3D 9809990
49. KB Reddy SM Nabha N Atanaskova 2003 Role of MAP kinase in tumor progression and invasion Cancer Metastasis Rev 22 4 395 403 1:CAS:528: DC%2BD3sXjslyiu7o%3D 10.1023/A:1023781114568 12884914 (Pubitemid 36791895)
50. M Qiao S Sheng AB Pardee 2008 Metastasis and AKT activation Cell Cycle 7 19 2991 2996 1:CAS:528:DC%2BD1cXhsVOgsrrL 18818526 Epub 2008 Oct 13